XYLANASE, OLIGONUCLEOTIDIC SEQUENCE ENCODING IT AND ITS USES

Abstract: Xylanase stable at 60 DEG C and having a sequence comprising 182 aminoacids, and oligonucleotidic sequence encoding it. This oligonucleotidic sequence, comprised in an appropriate vector, allows the production of xylanase.

Description: Xylanase, oligonucleotidic sequence encoding it and its uses The present invention relates to a xylanase and to a nucleotidic sequence encoding it. It also relates to the use of this enzyme in the bleaching of paper pulp and the preparation of xylose or of xylo-oligosaccha des from plant raw materials, in particular. Varied uses have been proposed for xylanases in the biotechnology field, especially in the foodstuffs field (Biely, Trends Biotechnol 3 (11 ): 286-290, 1985), in the paper industry (Mora et al., J. Wood Chem. Technol, 6: 147-165, 1986) or in the production of chemical compounds from hemicellulose (Reilly P.J., 1981 , Xylanases: structure and function in trends in the biology of fermentations for fuels and chemicals. A.J. Hollaender (Ed), Plenum, New York). The technical feasibility of such applications has been assessed chiefly using enzymes produced by mesophilic fungi. However, such applications could be facilitated by the use of fungi possessing better temperature stability. Various bacteria and enzymes are known for the production of xylanases ( see, in particular, Wong et al., Microbiological Reviews, 52, No 3 305 317, 1988). Hitherto, the highest yields of enzymes have been obtained from fungi (Yu et al. Enzymo Microb. Technol. 9: 16-24, 1987). However, hyperproductive strains of Bacillus have already been described (Okazaki et al. Appl. Microbiol. Biotechnology, 19: 335-340, 1984; Okazaki et al., Agric. Biol. Chem. 49, 2033-2039, 1985). Such thermophilic species of Bacillus which degrade xylan can be good candidates for the industrial production of xylanases on account of their high growth rate and of their genetics being well known. The xylanases isolated by Okazaki et al. emanate from two Bacillus strains referred to as W1 and W2 by the authors. In each of these strains, two components of the xylanase activity, referred to as I and II, have been demonstrated. The components I degrade xylan to xylobiose and to oligomers having a higher degree of polymerization, while the components II produce xylose in addition to the above compounds. The components I (referred to as W1.I and W2.I) have respective molecular weights of 21.5 kDa and 22.5 kDa, as well as isoelectric points of 8.5 and 8.3. The components II (W1.ll and W2.ll) have, for their part, respective molecular weights of 49.5 kDa and 50 kDa. The two components I and II are inhibited by Hg ' + ions and, to a lesser extent, by Cu "+ . Many other xylanases have been isolated from various species of Bacillus, Clostridium, Aspergillus, Streptomyces or Trichoderma, inter alia (Wong et al., 1988, cited above). Thus, the resume of Japanese Patent JP 130 96 84 (RIKAGAKU KENKYSHO) relates to a type Wll xylanase having a molecular weight of 5O kD or 42 kD. No isoelectric point is mentioned for this xylanase. A paper by RAJARAM et al., ( Applied Microbiology and Biotechnology, Vol. 34, n°1 , October 1990, pages 141-144) relates to a Bacillus strain isolated in the natural environment and which produces a xylanase having optimal activity at between 6O°C and 7O°C and at a pH of between 6 and 7. This enzyme is characterized neither by its molecular weight nor by its isoelectric point. This strain produces, in addition, other enzymes such as cellulases. Another resume of a Japanese patent in the name of RIKAGAKU KENKYUSHO (JP-85 118 644) describes a xylanase having optimal activity at a pH of between 6 and 7. This enzyme is considered to have a molecular weight, determined by ultrafiltration, of between 50 and 100 kD. No isoelectric point is mentioned in this resume. A paper by GRUNINGER et al. (Enzyme Microbiology and Technology, Vol. 8, May 1986, pages 309-314) relates to a Bacillus stearothermoplilus strain isolated from mud and which produces a heat- stable xylanase. The enzyme is characterised as having optimal activity at 78°C and at a pH value of 7.5. This enzyme is characterized neither by its molecular weight nor by its isoelectric pH. The industrial production of xylanases is impeded by the simultaneous presence of contaminant activities such as cellulases, leading to additional purification costs. As far as the Applicant is aware, the best productivity with respect to endoxylanase obtained with a microorganism not producing cellulase has been obtained from a Streptomyces lividans mutant devoid of cellulase activity after introduction of a plasmid carrying genes coding for xylanases A and B. Productivities of the order of 6OOO to 10,000 lU.I/h were observed in the culture media. It should nevertheless be noted that, in this case, problems linked to the failure of xylanase A to hydrolyse insoluble xylan, and of thermal stability in the case of xylanase B, were encountered (Kluepfel et al. Biochem. J. 267, 47-50, 1990). None of these enzymes hence possessed, as far as the Applicant is aware, features making an industrial application possible, that is to say good thermal stability, a large capacity for degradation of substrates, a means of production by hyperproductive strains and possibilities to modify the aminoacids sequence. Another xylanase has been isolated from a Bacillus strain deposited at the CNCM Culture Collection under the number 1-1017. It has been described in EP 0.573.536 application filed under the name of the present applicant. This xylanase displays a temperature stability. However its sequence has not been determined and it can only be produced by growing the said Bacillus strain. Thus it was not possible to modify its protein sequence in the aim of improving its properties. The applicant has thus cloned the gene encoding this xylanase and has sequenced it. The subject of the present invention is, thus a thermophilic xylanase having a sequence sharing an homology of at least 8O%, preferentially 90%, and more preferentially 95%, with the following one (SEQ ID N°2): Asn Thr Tyr Trp Gin Tyr Trp Thr Asp Gly lie Gly Tyr Val Asn Ala Thr Asn Gly Gin Gly Gly Asn Tyr Ser Val Ser Trp Ser Asn Ser Gly Asn Phe Val He Gly Lys Gly Trp Gin Tyr Gly Ala His Asn Arg Val Val Asn Tyr Asn Ala Gly Ala Trp Gin Pro Asn Gly Asn Ala Tyr Leu Thr Leu Tyr Gly Trp Thr Arg Asn Pro Leu He Glu Tyr Tyr Val Val Asp Ser Trp Gly Ser Tyr Arg Pro Thr Gly Asp Tyr Arg Gly Ser Val Tyr Ser Asp Gly Ala Trp Tyr Asp Leu Tyr His Ser Trp Arg Tyr Asn Ala Pro Ser He Asp Gly Thr Gin Thr Phe Gin Gin Tyr Trp Ser Val Arg Gin Gin Lys Arg Pro Thr Gly Ser Asn Val Ser He Thr Phe Glu Asn His Val Asn Ala Trp Gly Ala Ala Gly Met Pro Met Gly Ser Ser Trp Ser Tyr Gin Val Leu Ala Thr Glu Gly Tyr Tyr Ser Ser Gly Tyr Ser Asn Val Thr Val Trp The degree of homology can be determined using pairwise alignment methods such as the GAP and the BESTFIT programs of the Genetics Computer Group, Inc. Package (GCG) Fast database searching programs such asd FASTA and BLAST (included in the GCG package) can be used for the comparison of a sequence to all available sequences of a database. For the definition of the term "homology" one can refer to Altschul et al. (1990, J. Mol. Biol. 215, 403-410) and Doolittle R.F. (Ed) (Molecular evolution: computer analysis of protein and nucleic acid sequences. Methods in Enzymology 183, Academic Press, London, 1990). Xylanases falling under this definition are in particular the ones in which one or a few aminoacids have been changed, compared to the sequence SEQ ID N°2. Such changes in the aminoacids are preferentially the ones which consist in the substitution of one aminoacid by another one which has substantially the same properties such as defined by Lehπinger (page 7O, 2nd french edition, 1979, Flammarion ed.) or in its more recent re-edition. It is reminded that the twenty basic aminoacids are classified in four groups depending on their properties: - the ones having a hydrophobic or non-polar lateral chain, - the ones having a polar lateral chain not charged, - the ones having a negatively charged lateral chain, and - the ones having a positively charged lateral chain. Such a xylanase can possess a molecular mass of approximately 22 kDa, determined by SDS-PAGE, or 20.7 kDa determined by mass spectroscopy and an isoelectric point of approximately 7.7. This enzyme advantageously displays great stability at 6O°C for at least 24 hours, and a pH of optimal activity within the range extending from 4.8 to 7, and preferably approximately 6. It should be noted that the pHj of this enzyme is fairly high but nevertheless lower than the pHj of the xylanases of similar molecular mass produced by some bacilli, in particular those described by Okazaki et al. (1985, publication cited above). pH 6 corresponds to an optimal pH, but the activity remains greater than 80% in the range between 4.8 and 7. Another subject of the present invention is a nucleotidic sequence coding for the said xylanase. This sequence can be DNA or RNA sequence and in particular c DNA, plasmidic DNA, genomic DNA or m RNA. Preferentially such a nucleotidic sequence is the following one (SEQ ID N°1 ): aacacgtactggcagtattggacggatggcatcgggtatgtgaacgcgacgaacggaca aggcggcaactacagcgtaagctggagcaacagcggcaacttcgtcatcggcaagggct ggcaatacggtgcgcacaaccgggttgtcaactacaacgccggcgcatggcagccgaa cggcaacgcgtatctgacgctgtacggctggacgcgcaacccgctcatcgaatactacgt cgtcgacagctggggcagctaccgcccgaccggcgactaccggggcagcgtgtacagc gacggcgcatggtatgacctctatcacagctggcgctacaacgcaccgtccatcgacggc acgcagacgttccaacaatactggagcgttcgtcagcagaaacgcccgacgggcagcaa cgtctccatcacgttcgagaaccacgtgaacgcatggggcgctgccggcatgccgatgg gcagcagctggtcttaccaggtgctcgcaaccgaaggctattacagcagcggatactcca acgtcacggtttggtaa The xylanase according to the present invention can thus also be produced by a microorganism strain, appropriately chosen, transformed by a vector coding for the said xylanase. The said microorganism is grown in an appropriate medium and thereafter the xylanase is isolated as described below. Such a microorganism is chosen in order to be able to produce and to excrete it. It can be a bacteria such as Esche chia coli or Bacillus sp. The vector coding for the xylanase is chosen in order to be expressed in the said microorganism. It can be a plasmid, such as pBluescript or preferentially pET.. Systems of expression suitable for the production of the xylanase according to the present invention are in particular listed in D.V. Goeddel ((Ed). Gene expression technology. Methods in Enzymology, 185, Academic Press, London, 1990). The pET E.coli expression system is one of the most widely used bacterial expression system (Studier et al., 1990, Meth. Enzymol., 185, 60-89). The expression of recombinant xylanase can be achieved in particular as following. The DNA fragment encoding the mature xylanaxe, i.e. the sequence SEQ ID N°1 , is engineered by PCR so as to generate Ndel and Bamhl terminal restriction sites suitable for expression in the T7-based vector pET3a. The PCR fragment is cloned blunt-ended into pBluescript (Stratagene Cloning Systems) before cloning as a Ndel/BamHI fragment into pET3a. The recombinant enzyme is expressed from pET3a in the E. coli strain BL21 (DE3) carrying pLysS. Cultures are grown in L-broth containing ampicillin (100 μg/ml) and chloramphenicol (25 μg/ml) until an A 600 °f 3 was reached, before induction with 0.1 mM isopropyl β-D- thiogalactoside (IPTG) for 3 hours. Large-scale cultures for protein purification are centrifuged and the cells are lysed in a buffer containing 5O mM Tris-HCI, pH 8.O, 1 mM EDTA by passage through a French press (10 MPa). The same process described in EP 0.573.536 for purifying the xylanase from the culture supernatant of the Bacillus can be used. One can expect about 1 mg of recombinant protein per ml of cell culture. An advantage of this way of production of the xylanase is that the nucleoditic sequence can be mutated before to be introduced in the microorganism. It is therefore easy to obtain various mutations corresponding to xylanases having various sequences. This was not possible with the thermostable xylanases already described in the prior art, such as the one described by GRUNINGER et al. (previously cited), since their sequences were not known. For carrying out the present invention, in particular this way of production, the man skilled in the art can refer to the following manual which describes the usual techniques of molecular biology: Maniatis et al. 1982- Molecular Cloning: a Laboratory Manual, Cold Spring Harbor Ed. New York, or one of its more recent editions. The xylanase as described above can be obtained through a process, comprising the following steps: - concentration of the microorganism culture supernatant, - passage through an ion exchange column such as a column of Q Sepharose Fast Flow (Pharmacia), - passage through a hydrophobic interaction column such as a column of Phenyl-Sepharose (Pharmacia). Concentration of the supernatant can , in particular, be performed by ultrafiltration through a polysulphone membrane having an exclusion threshold above 10 kDa. This process enables a substantially pure xylanase preparation to be obtained. The xylanase described above can be produced through a process comprising the steps: - of growth of the bacteria in a medium containing a growth substrate such as glucose, and - of production of xylanase induced by feeding the culture continuously with suitable amounts of xylo-oligosaccharides. The subject of the present invention is also the use of the xylanase described above in the bleaching of paper pulp. An advantage of this xylanase lies in the fact that the degree of hydration of the paper pulp is of little importance. It is not obligatory to dilute the pulp greatly in order to obtain good enzymatic attack. The use of this xylanase as an auxiliary in the bleaching of paper pulp is all the more advantageous for the fact that the preparations are devoid of cellulase contaminants. This xylanase may also be used for the preparation of xylose or of xylo-oligosaccharides from raw materials of plant origin, which are inexpensive and renewable raw materials (for example maize cobs). Other uses of xylanases have been mentioned in the literature. The review by Zeikus et al. (Thermostable saccharidases New Sources uses and Biodesigns in "Enzymes in biomass conversion", Leatham and Himmel, ACS Washington D.C. , 1991 ) lists the main uses of xylanases. They are mainly used in food manufacture, where their properties enable bread-making, the clarification of fruit juices and wines and the nutritional qualities of cereal fibres to be improved, and in the production of thickeners for foodstuffs. The second sphere of application relates to the paper pulp and fibre industries, where they are used for the bleaching of pulps, the manufacture of wood pulp and the purification of fibres for rayon manufacture. Uses are also noted in poultry feeding, in which uses xylanases are employed in order to decrease the viscosity of the feeds (Van Paridon et al. Xylans and Xylanases, International Symposium, Wageningen, 8-11 December 1991 ; Bedford and Classen H.L Xylans and Xylanases, International Symposium, Wageningen, 8-11 December 1991 ). The use of xylanase in enhancing the value of by-products of the paper pulp industry is more specifically mentioned in the paper by Biely (Trends in Biotechnology, Vol.3, No.11 , 1985). Mention may also be made of the two European Patents EP 228,732 and EP 227,159, which relate to the use of Xylanases for improving the filterability of glucose syrup and of beer, respectively. The possibility of using the xylanases for the production of chemical compounds from hemicellulose (Reilly, cited above) will also be noted. These various publications show that the xylanases which are the subject of the present invention may be used in a large number of applications, The present invention is illustrated, without, however, being limited, by the application examples which follow. Fig. 1 illustrates the homology degree between the xylanase according to the present invention (XYL2O) and other xylanases. Fig.2 represents HCA plots of four xylanases, including the one of the present invention. On fig.3 is indicated the prediction of secondary structural elements for the xylanase of the present invention. EXAMPLE 1: Cloning and sequencing of the gene encoding for the xylanase. 1. Materials and methods. - Strains, vectors and culture conditions. The strain 1-1017 was grown at 55°C in the liquid medium described in examples 1 and 2 of patent application EP-0.573.536. The SURE, XL1-Blue and XLOLR Escherichia coli strains, the vectors ZAP Express and pBluescript and the filamentous helper phage ExAssist™ were all purchased from Stratagene Cloning Systems E. coli cells were grown in LB medium at 37°C. The medium was solidified by addition of 1.5% (w/v) of Bacto-agar. - Preparation of DNA Bacterial genomic DNA was extracted from 1-1017 according to the method of Yang et al. (Appl. Environ. Microbiol., 1988, 54, 1023- 1029). - Obtention of a partial genomic clone coding for the XYL2Q PCR was used to amplify a region of the chromosomal DNA coding for the XYL2O. The nucleotide sequence of the forward primer (P1 ) (SEQ ID N°3) was AAYACNTAYTGGCARTAYTGGACNGAYGG (derived from the sequence NTYWQYWTDG in the N-terminus end of the XYL2O); that of the reverse primer (P2) (SEQ ID N°4) was YTGWCKNACRCTCCARTAYTG (corresponding to the sequence QYWSVRQ, a conserved region near the C-terminus of other xylanases from different Bacillus species). PCR was performed with chromosomal DNA as a template and the primers P1 and P2 on a thermocycler (Perkin-Elmer. France) with the following temperature profile: 1 min 94°C -1 min 5O°C - 2 min 72°C for 35 cycles. The PCR product was purified on a 1 % agarose gel and was ligated into EcoRV-digested pBluescript. The chimaeric plasmid (pBX2O) was used to transform SURE cells. Recombinant cells were selected on L-agar plates containing ampicillin (4O μg/ml), isopropyl-β-D-thiogalactoside (O.2 mM) and 5-bromo-4- chloro-3-indolyl-β-D-galactoside (4O μg/ml). - Construction of a B. sp 1-1017 genomic library in ZAP Express. Chromosomal DNA was partially digested with Sau3AI and the resulting DNA fragments in the size range 1.5-8 kb were purified and ligated into BamHI-digested ZAP Express. The library was constructed using XL1-Blue cells as indicated by the manufacturer. - Screening of the genomic library. pBX2O was digested with BamHI and Hindlll and the DNA insert was purified and labeled with digoxigenin (Boehringer Mannheim) following the instructions of the manufacturer. The labeled DNA was used to screen the genomic library. After the third screening, positive lambda plaques were isolated and the recombinant plasmid pBK-CMV inserted in the vector ZAP Express was excised using the filamentous phage ExAssist and then recovered by infecting the XLOLR cells in the presence of kanamycin (10 μg/ml). - DNA seguence analysis. Plasmid preparations for sequence determination were performed using Qiagen tip 100 (Diagen, Coger, France). Double- stranded DNA sequencing was done by the dideoxy chain termination method of Sanger et al (Proc. Nat. Acad. Sci. USA, 1977, 74, 5463- 5467), using the Sequenase™ 2.0 DNA sequencing kit from United States Biochemical . Both universal and specific primers were used to sequence the sense and antisense strands of inserts in the plasmids. - Protein sequence analysis and Hydrophobic Cluster Analysis. The sequence Analysis Software Package by Genetics Computer, Inc. (The GCG Package) was used throughout this work. In particular, multiple alignments were performed using the Pileup program and pairwise comparisons were done using the Bestfit program. Hydrophobic Cluster Analysis (HCA) is a method to compare amino acid sequence (Gaboriaud et al. FEBS Lett., 1987, 224, 149-155) which is derived from the theory of Lim (J. Mol. Biol, 1974, 88, 857-872). The method involves the drawing of the sequence of a theoretical A-helix where the hydrophobic residues form clusters. The shape, size and the relative position of the clusters can be compared and the sequence similarity, when it exists, may be readily revealed. Conversion of the amino acid sequences into the 2D-helical plot required by the method was made using the HCA-Plot software. 2) Results. In a first attempt to determine the xylanase sequence, the xylanatic activity has been tested in the genomic library. However this approach has failed to conduct to the isolation of the xylanase according to the present invention. In a second and successful attempt, the sequence of this xylanase has finally been determined. It is reminded that the amino acid sequence of the N-terminal region of the xylanase has been determined (example 4 of EP 0.573.536). It exhibits 67% of identity with the N-terminus of the xylanases produced by Bacillus subtilis and Bacillus circulans. Besides, these enzymes which belong to the G family (according to the classification of Gilkes et al. (Microbiol. Rev., 1991 , 55, 303-315)) share some conserved regions along their polypeptide chains. Among others, one region consisting of 7 amino acids occurs near the C-terminus. A part of the gene coding for the xylanase has been amplified by PCR using two degenerate primers, P1 and P2, corresponding to the N-terminus end of the xylanase and to a conserved region near the C- terminus, respectively. A 450 bp DNA fragment was obtained and cloned into the vector pBluescript. The sequence of the resultant plasmid pBX2O can be attributed without any doubt to the xylanase. To get the complete gene of xylanase, a genomic library of B. sp 1-1017 was prepared in E. coli XL1-blue using the phage vector ZAP Express. This library was screened with the insert of the plasmid pBX2O. One positive plaque, designated pBX52A2, was shown to contain the complete gene of the xylanase. The nucleotidic sequence of this clone is indicated in the sequence list hereunder as SEQ ID N° 1. The complete protein sequence of the xylanase is shown as SEQ ID N°2 is the sequence list hereunder. The results of a FASTA search in the protein data bases PIR and Swiss-Prot yielded 36 xylanase sequences. As shown in the table the xylanase shares sequence homology with other xylanases of the G family. The best scores (73% of identity) are observed as expected with the xylanases from B. subtilis and B. circulans. This shows unambiguously that the xylanase according to the present invention is a new protein which possesses a unique amino acid sequence. For comparative purposes, only representative xylanases from different organisms (the ones in bold types on the table ) are listed in the multiple sequence alignment shown in figure 1. The analysis of a primary sequence alignment of 14 xylanases of the G family indicates the residues which are conserved throughout the family. As reported previously by Wakarchuk et al., (Protein Sci., 1988, 3, 467-475), 2 glutamic acid residues are absolutely conserved in this family of xylanases. The present multiple alignment suggests that Glu76 and Glu169 are the catalytic residues of the xylanase. Alignment was then reconsidered by the HCA method (Gaboriaud et al., 1987, previously cited), which allows for a rapid identification of the clusters and an easy alignment (figure 2). The identification of the clusters is straightforward even if there are some variations in cluster shapes. The alignment was checked on crystalline structures for three xylanases indicated in figure 1 , and the extensions of the β-strands are indicated on the HCA plots. Vertical lines have been inserted to delimit the extension of β-strands. The most conserved hydrophobic clusters have been shadowed for better visualization. For the HCA plot of xylanase according to the present invention (XYL2O), the extension of the β-strands was deduced from the other plots. It appears clearly that the secondary structure of XYL2O consists essentially of β-strands and only one A-helix. These elements are so organized to display the characteristic folding of a greek key. We can also inferred that the following aromatic residues: Tyr 67 and Tyr 78 on one β-strand and Tyr 163 on another β-strand are likely to be involved in the orientation and binding of xylan polysaccharides, prior their hydrolysis. The figure 3 summarizes the prediction of the occurrence of secondary structural elements which can be proposed for the xylanase according to the present invention on the basis of its primary structure and a thorough protein sequence analysis. These structural predictions can be translated into a putative three-dimensional model to be used in Molecular Isomorphism Replacement in view of solving the crystalline structure of this xylanase. T.ible Summarv of wlanases cerr.ed from i STA se?ιch m f ne Protein Data Bases Swiss Prot (release 310) and PIR (release 440; XYNA 73 213 23,345 XYLC Al) 240 25,673 S 7512 1301 y^ SlreptuimLcx sp ECS 58 240 IS0590 100194 StiupionivcLt Imdetiif XYLB 58 1. P26515 0! 0892 XYNB 58 133 1 426 S43919 25 IOV4 Hitiii la IIIMIIL'IIS 55 227 Tridivilerina iirnle XY IIA 54 190 XYLΠB 3 190 Trichoderma reesei XYN2 54 222 24,172 XYLI XYLΠ Scluztiplixtliiiti Liniiiiiiiiie 54 197 20,978 Ludihoh livi urhnmuii 53 221 23,728 TπclioiLrniti lianiaiiimi 51 190 Uu lltis piiiiiilus XYNA 50 228 25,521 Clnstriiliiiiii ster nrurinin XYLA 48 511 48 511 36.519 Cliislridiiiiii aι.elι>hιιt\ licitin 46 261 29,032 22,560 JC 1198 011 ) iitvii XYNC 40 211 XYNI 19 229 24581 XY 2 17 266 15 607 XYLA 15 607 XYNA 14 607 6175 P35SII 010295 [ ibinhtitler vιιtιι.ιt>)icιιt.ι 14 608 66415 (1) AC ΛL-I:-,MOII Number (2) cnsi rv jllouru lut .ii.i. .iil bltf ( ) % pcri-oiii Utf ol idtfiiinv ϋnh the .equeικ.<:_ in bold on liiiure 2 SUBSTITUTE SHEET (RULE 26 SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE(INRA) (B) STREET: 147, rue de I'Universite (C) CITY: PARIS (E) COUNTRY: FRANCE (F) POSTAL CODE (ZIP): 75341 (G) TELEPHONE: 42 75 90 00 (H) TELEFAX: 42 75 94 28 (ii) TITLE OF INVENTION: XYLANASE, OLIGONUCLEOTIDIC SEQUENCE ENCODING IT AND ITS USES (iii) NUMBER OF SEQUENCES: 4 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.30 (EPO) (v) CURRENT APPLICATION DATA: APPLICATION NUMBER: US 08/543.956 (2) INFORMATION FOR SEQ ID NO: 1 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 549 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Bacillus sp (B) STRAIN: 1-1017 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION:! ..547 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1 : AAC ACG TAC TGG CAG TAT TGG ACG GAT GGC ATC GGG TAT GTG AAC GCG 48 Asn Thr Tyr Trp Gin Tyr Trp Thr Asp Gly He Gly Tyr Val Asn Ala 1 5 10 15 ACG AAC GGA CAA GGC GGC AAC TAC AGC GTA AGC TGG AGC AAC AGC GGC 96 Thr Asn Gly Gin Gly Gly Asn Tyr Ser Val Ser Trp Ser Asn Ser Gly 20 25 30 AAC TTC GTC ATC GGC AAG GGC TGG CAA TAC GGT GCG CAC AAC CGG GTT 144 Asn Phe Val lie Gly Lys Gly Trp Gin Tyr Gly Ala His Asn Arg Val 35 40 45 GTC AAC TAC AAC GCC GGC GCA TGG CAG CCG AAC GGC AAC GCG TAT CTG 192 Val Asn Tyr Asn Ala Gly Ala Trp Gin Pro Asn Gly Asn Ala Tyr Leu 50 55 60 ACG CTG TAC GGC TGG ACG CGC AAC CCG CTC ATC GAA TAC TAC GTC GTC 240 Thr Leu Tyr Gly Trp Thr Arg Asn Pro Leu lie Glu Tyr Tyr Val Val 65 70 75 80 GAC AGC TGG GGC AGC TAC CGC CCG ACC GGC GAC TAC CGG GGC AGC GTG 288 Asp Ser Trp Gly Ser Tyr Arg Pro Thr Gly Asp Tyr Arg Gly Ser Val 85 90 95 TAC AGC GAC GGC GCA TGG TAT GAC CTC TAT CAC AGC TGG CGC TAC AAC 336 Tyr Ser Asp Gly Ala Trp Tyr Asp Leu Tyr His Ser Trp Arg Tyr Asn 100 105 110 GCA CCG TCC ATC GAC GGC ACG CAG ACG TTC CAA CAA TAC TGG AGC GTT 384 Ala Pro Ser lie Asp Gly Thr Gin Thr Phe Gin Gin Tyr Trp Ser Val 115 120 125 CGT CAG CAG AAA CGC CCG ACG GGC AGC AAC GTC TCC ATC ACG TTC GAG 432 Arg Gin Gin Lys Arg Pro Thr Gly Ser Asn Val Ser lie Thr Phe Glu 130 135 140 AAC CAC GTG AAC GCA TGG GGC GCT GCC GGC ATG CCG ATG GGC AGC AGC 480 Asn His Val Asn Ala Trp Gly Ala Ala Gly Met Pro Met Gly Ser Ser 145 150 155 160 TGG TCT TAC CAG GTG CTC GCA ACC GAA GGC TAT TAC AGC AGC GGA TAC 528 Trp Ser Tyr Gin Val Leu Ala Thr Glu Gly Tyr Tyr Ser Ser Gly Tyr 165 170 175 TCC AAC GTC ACG GTT TGG T AA 549 Ser Asn Val Thr Val Trp 180 (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 182 ammo acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2. Asn Thr Tyr Trp Gin Tyr Trp Thr Asp Gly lie Gly Tyr Val Asn Ala 1 5 10 15 Thr Asn Gly Gin Gly Gly Asn Tyr Ser Val Ser Trp Ser Asn Ser Gly 20 25 30 Asn Phe Val He Gly Lys Gly Trp Gin Tyr Gly Ala His Asn Arg Val 35 40 45 Val Asn Tyr Asn Ala Gly Ala Trp Gin Pro Asn Gly Asn Ala Tyr Leu 50 55 60 Thr Leu Tyr Gly Trp Thr Arg Asn Pro Leu lie Glu Tyr Tyr Val Val 65 70 75 80 Asp Ser Trp Gly Ser Tyr Arg Pro Thr Gly Asp Tyr Arg Gly Ser Val 85 90 95 Tyr Ser Asp Gly Ala Trp Tyr Asp Leu Tyr His Ser Trp Arg Tyr Asn 100 105 110 Ala Pro Ser lie Asp Gly Thr Gin Thr Phe Gin Gin Tyr Trp Ser Val 115 120 125 Arg Gin Gin Lys Arg Pro Thr Gly Ser Asn Val Ser He Thr Phe Glu 130 135 140 Asn His Val Asn Ala Trp Gly Ala Ala Gly Met Pro Met Gly Ser Ser 145 150 155 160 Trp Ser Tyr Gin Val Leu Ala Thr Glu Gly Tyr Tyr Ser Ser Gly Tyr 165 170 175 Ser Asn Val Thr Val Trp 180 (2) INFORMATION FOR SEQ ID NO: 3. (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic.degenerate oligonucleotide" (iii) HYPOTHETICAL: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: AAYACNTAYT GGCARTAYTG GACNGAYGG 29 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic, degenerate oligonucleotide" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: YES (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: YTGWCKNACR CTCCARTAYT G 21 SUBSTITUTE SHEET (RULE 26

Claims: CLAIMS: 1. Xylanase having a sequence, sharing an homology of at least 80%, and preferentially 90%, with the one having the following sequence SEQ ID N°2: Asn Thr Tyr Trp Gin Tyr Trp Thr Asp Gly lie Gly Tyr Val Asn Ala Thr Asn Gly Gin Gly Gly Asn Tyr Ser Val Ser Trp Ser Asn Ser Gly Asn Phe Val lie Gly Lys Giy Trp Gin Tyr Gly Ala His Asn Arg Val Val Asn Tyr Asn Ala Gly Ala Trp Gin Pro Asn Gly Asn Ala Tyr Leu Thr Leu Tyr Gly Trp Thr Arg Asn Pro Leu lie Glu Tyr Tyr Val Val Asp Ser Trp Gly Ser Tyr Arg Pro Thr Gly Asp Tyr Arg Gly Ser Val Tyr Ser Asp Gly Ala Trp Tyr Asp Leu Tyr His Ser Trp Arg Tyr Asn Ala Pro Ser Me Asp Gly Thr Gin Thr Phe Gin Gin Tyr Trp Ser Val Arg Gin Gin Lys Arg Pro Thr Gly Ser Asn Val Ser lie Thr Phe Glu Asn His Val Asn Ala Trp Gly Ala Ala Gly Met Pro Met Gly Ser Ser Trp Ser Tyr Gin Val Leu Ala Thr Glu Gly Tyr Tyr Ser Ser Gly Tyr Ser Asn Val Thr Val Trp 2. Xylanase according to claim 1 , which is stable at approximately 6O°C for 24 hours. 3. Xylanase according to one of the claims 1 and 2, which is secreted by a microorganism strain, appropriately chosen, transformed by a vector encoding the said xylanase. 4. Nucleotidic sequence coding for the xylanase according to one of the claims 1 to 3. 5. Nucleotidic sequence having the following sequence SEQ ID N°1 : aacacgtactggcagtattggacggatggcatcgggtatgtgaacgcgacgaacggaca aggcggcaactacagcgtaagctggagcaacagcggcaacttcgtcatcggcaagggct ggcaatacggtgcgcacaaccgggttgtcaactacaacgccggcgcatggcagccgaa cggcaacgcgtatctgacgctgtacggctggacgcgcaacccgctcatcgaatactacgt cgtcgacagctggggcagctaccgcccgaccggcgactaccggggcagcgtgtacagc gacggcgcatggtatgacctctatcacagctggcgctacaacgcaccgtccatcgacggc acgcagacgttccaacaatactggagcgttcgtcagcagaaacgcccgacgggcagcaa cgtctccatcacgttcgagaaccacgtgaacgcatggggcgctgccggcatgccgatgg gcagcagctggtcttaccaggtgctcgcaaccgaaggctattacagcagcggatactcca acgtcacggtttggtaa 6. Vector, in particular plasmid, comprising a sequence according to one of the claims 4 and 5. 7. Process for the production of a xylanase having the sequence SEQ ID N°2, or sharing an homology of at least 80% and preferentially 90%, with SEQ ID N°2 wherein: - a microorganism strain appropriately chosen and transformed by a vector encoding the said xylanase according to claim 6 is grown in an appropπate medium, and - the xylanase is isolated.

Inventors: BRETON CHRISTELLE, DEBEIRE PHILIPPE, PEREZ SERGE, BRETON, CHRISTELLE, DEBEIRE, PHILIPPE, PEREZ, SERGE
Applicants: AGRONOMIQUE INST NAT RECH, BRETON CHRISTELLE, DEBEIRE PHILIPPE, PEREZ SERGE, BRETON, CHRISTELLE, DEBEIRE, PHILIPPE, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, PEREZ, SERGE
Application year: 1996
Main classification: C12N15
IPC codes: C12N1, C12N9, C12N15, C12R1